本文已被:浏览 183次 下载 174次
投稿时间:2025-10-24 网络发布日期:2026-09-24
投稿时间:2025-10-24 网络发布日期:2026-09-24
中文摘要: 目的 探讨氢氯噻嗪联合综合消肿疗法(CDT)对乳腺癌术后淋巴水肿的疗效,及其对患者肩关节活动度、上肢功能、炎症因子水平的影响。方法 选取西安交通大学第一附属医院于2021年9月至2024年9月收治的110例乳腺癌术后淋巴水肿患者作为研究对象,随机分为对照组(行CDT)和试验组(CDT+氢氯噻嗪片口服),各55例,比较两组的临床疗效、患肢周径、上肢关节活动度、上肢功能[采用手臂、肩和手功能障碍(DASH)评分系统评估]、炎症因子水平及生活质量[采用生命质量(QOL)评分评估]。结果 试验组总有效率高于对照组(92.73% vs 78.18%,χ2=4.681,P=0.031)。治疗后,试验组肩关节活动度、QOL 评分均高于对照组(P<0.05),患肢周径、DASH 评分、肿瘤坏死因子-α、白细胞介素-6 和C 反应蛋白水平低于对照组(P<0.05)。治疗后,试验组和对照组不良反应总发生率比较,差异无统计学意义(9.09% vs 10.91%,χ2=0.101,P=0.751)。结论 采用氢氯噻嗪联合CDT 疗法,针对乳腺癌术后淋巴水肿的治疗可取得明显成效,能够显著改善关节活动范围、增强上肢功能,同时减轻炎症症状,提高患者的生活品质。
Abstract:Objective To investigate the efficacy of hydrochlorothiazide combined with complete decongestive therapy(CDT)in treating postoperative lymphedema in breast cancer patients,as well as its impact on shoulder range of motion,upper limb function,and inflammatory cytokine levels. Methods A total of 110 breast cancer patients with postoperative lymphedema admitted to The First Affiliated Hospital of Xi’an Jiaotong University from September 2021 to September 2024 were enrolled as the study subjects. They were randomly assigned into the control group(receiving CDT alone)and the experimental group (CDT plus oral hydrochlorothiazide tablets),each had 55 cases. The clinical efficacy,limb circumference,upper limb joint mobility,upper limb function[assessed by the Disabilities of the Arm,Shoulder and Hand(DASH)scoring system],inflammatory factor levels,and quality of life[assessed by the Quality of Life(QOL)scale]were compared between the two groups. Results The total effective rate of the experimental group was higher than that of the control group (92.73% vs 78.18% ,χ2=4.681,P=0.031). After treatment,the experimental group had higher shoulder joint mobility and QOL score(P<0.05),and smaller diseased limb circumference,lower DASH score,lower levels of tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),and C-reactive protein(CRP)than the control group(P<0.05). After treatment,there was no statistically significant difference in the total incidence of adverse reactions between the experimental group and the control group(9.09% vs 10.91%,χ2=0.101,P=0.751). Conclusion Hydrochlorothiazide combined with CDT has achieved obvious results in treating postoperative lymphedema of breast cancer patients. It can obviously improve joint mobility,enhance upper limb function,alleviate inflammatory symptoms,and improve quality of life.
keywords: Hydrochlorothiazide Complete decongestive therapy Breast cancer Lymphedema Upper limb function Inflammatory factor
文章编号: 中图分类号:R737.9 R619 文献标志码:A
基金项目:陕西省重点研发计划项目(S2025-YF-YBSF-1292)
附件
| Author Name | Affiliation |
| LU Jue,ZHANG Hui,FAN Weijing,WANG Zhen,GAO Jing | Department of Tumor Radiotherapy,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi 710061,China |
引用文本:
陆珏,张惠,范玮婧,王珍,高静.氢氯噻嗪联合综合消肿疗法治疗乳腺癌术后淋巴水肿[J].中国临床研究,2026,39(9):1345-1349.
陆珏,张惠,范玮婧,王珍,高静.氢氯噻嗪联合综合消肿疗法治疗乳腺癌术后淋巴水肿[J].中国临床研究,2026,39(9):1345-1349.
